Aquatic Veterinary Market is expected to reach US$ 2.00 Billion by 2031

Treatment Segment Based on Type Fuels Aquatic Veterinary Market Growth

According to our new research study on “Aquatic Veterinary Market Forecast to 2031 – Global Analysis – by Type, Species, Diseases Source, and Route Of Administration,” the market size is expected to grow from US$ 1.54 billion in 2024 to US$ 2.00 billion by 2031; the market is expected to register a CAGR of 7.57% during 2025–2031. Major factors driving the growth of the aquatic veterinary market include the growing consumption of seafood products and the expanding aquaculture industry.

In 2022, the production of aquatic animals amounted to 185.4 million metric tons, alongside 37.8 million metric tons of algae. The intensified aquaculture practices fuel the increase in production as a result of the growing seafood demand, rising population, and decreasing wild seafood supplies. Aquatic veterinary care products, diagnostics, vaccines, and biosecurity controls face new challenges in increased pathogens, parasites, and environmental stressors requiring stringent controls. Analogously, the aquatic veterinary industry is also flourishing, and it is anticipated to grow as aquaculture expands, necessitating effective and timely preventive treatments for curtailing the mounting economic losses, which are projected to reach billions each year.

Aquatic Veterinary Market, by Region, 2024(%)

Source: The Insight Partners Analysis

In November 2023, Merck Animal Health launched AQUA CARE365, an online education platform with interactive modules and expert resources for aquatic veterinarians. This initiative aims to improve veterinary skills in managing the health of aquatic animals as aquaculture operations expand.

CRISPR/Cas9 technology has transformed modern aquaculture by enabling the genetic improvement of key traits in different fish species. For example, researchers have successfully removed germ cells that cause sex differentiation in Atlantic salmon, improved feed conversion efficiency to accelerate the growth rates of yellow catfish, and achieved targeted gene mutations in tilapia while minimizing off-target effects.

Rising aquaculture production and increasing technology advancements are projected to be key drivers shaping aquatic veterinary market trends in the near future.

Aquatic Veterinary Market Analysis Based on Segmental Evaluation:

Based on type, the market is segmented into diagnostic and treatment. The treatment segment held a larger aquatic veterinary market share in 2024 and is expected to register the highest CAGR during 2025–2031. Veterinary aquatic procedures assist with medical complications in fish, crustaceans, and mollusks. Treatments within this realm are equally compatible with aquatic medical procedures, as they cover aquatic crustaceans and mollusks, fish, and other marines. The aquatic and veterinary procedures focus on and cover bacterial, viral, and other parasitic infections as well as genetical and environmental infections and stress-inducing infections. Current medical procedures and aquatic biomediicines aim to provide a holistic medicinal treatment for infections and weaken and boost the diseases present in aquatic animals and other viral and bacterial infections. Aquatic species vaccines are increasingly becoming used as a form of treatment to curb widespread bacterial infections, as well as increasing the species' immunity to infections. Thus, it reduces the use of antibiotics on aquatic species. Countries leading in the production of salmon, such as Chile and Norway, have adopted biosecurity measures, including the use of these vaccines, to curb any potential outbreaks. This new approach is highly encouraged within the industry as the use of these vaccines decreases the use of antibiotics and is a solution to the threats of AMR.

The global aquatic veterinary market, by species, is segmented into fish, crustaceans, mollusca, and others. The fish segment held the largest share of the aquatic veterinary market in 2024 and is expected to register a higher CAGR during 2025–2031.

In terms of diseases source, the global aquatic veterinary market is segmented into bacterial, viral, parasites, and others. The bacterial segment held the largest share of the aquatic veterinary market in 2024 and is anticipated to register the highest CAGR during 2025–2031.

The market, by route of administration, is segmented into water medication, medicated feed, and other route of administrations. The water medication segment held the largest share of the aquatic veterinary market in 2024.

The scope of the aquatic veterinary market report includes an assessment of the market performance in North America, Europe, Asia Pacific, South and Central America, and the Middle East and Africa. In terms of revenue, North America dominated the aquatic veterinary market share in 2024. The freshwater aquaculture industry in the US is led by catfish farming in Mississippi, which, unlike the rest of the US, requires a veterinary certificate for managing diseases and maintaining biosecurity. 75–90% of seafood in the US relies on imports. The demand for seafood is the function of the tastes and preferences of finfish and shellfish consumers since 1990, and till 2022, seafood demand has gone through a series of ups and downs. There has been a 38% increase in per capita seafood consumption during this period, reaching 20.8 pounds a person in 2022. Shifting the focus to veterinary products increases the demand to contain vaccines, diagnostics, and therapeutics to maintain health in intensive for-availing high stocking densities, and the risks of disease are a sustainable shift to offshore and indoor farming systems.

Merck KGaAPfizer Inc, Novartis AG, Bristol-Myers Squibb Co, Amgen Inc, F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc, GSK Plc, Iovance Biotherapeutics Inc, Genentech Inc. are among the leading companies profiled in the aquatic veterinary market report.

In terms of geography, the market is categorized into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America is the largest contributor to the growth of the aquatic veterinary market, primarily due to a surge in the aquaculture industry and an increase in the demand for foods derived from aquatic animals is driving the market growth.

The aquatic veterinary market in Asia Pacific is projected to experience the fastest growth during the forecast period. Governments across Asia Pacific are implementing policies and funding to bolster aquaculture and aquatic animal health, recognizing their economic and food security importance. Expansion and product launch strategies implemented by market players are expected to contribute to the growth of the aquatic veterinary market in the region in the coming years.

Contact Us

Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com